GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Inspire Medical Systems Inc (FRA:2DR) » Definitions » Valuation Rank

Inspire Medical Systems (FRA:2DR) Valuation Rank


View and export this data going back to 2018. Start your Free Trial

What is Inspire Medical Systems Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Inspire Medical Systems Valuation Rank Related Terms

Thank you for viewing the detailed overview of Inspire Medical Systems's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Inspire Medical Systems (FRA:2DR) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Inspire Medical Systems Inc (FRA:2DR) » Definitions » Valuation Rank
Comparable Companies
MASI QDEL NARI GKOS CNMD IART ITGR LIVN AXNX IRTC ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
INSP:USA 2DR:Germany
Address
5500 Wayzata Boulevard, Suite 1600, Golden Valley, MN, USA, 55416
Website
https://www.inspiresleep.com
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.